Respiratory delivery of theophylline by size-targeted starch microspheres for treatment of asthma

References

• Atyabi F, Manoochehri S, Moghadam SH, Dinarvand R. Cross-linked starch microspheres: Effect of cross-linking condition on the microsphere characteristics. Arch Pharm Res 2006; 29: 1179–1186
   PubMed Web of Science ®Google Scholar
• Bajpai AK, Bhanu S. Dynamics of controlled release of heparin from swellable crosslinked starch microspheres. J Mater Sci Mater Med 2007; 18: 1613–1621
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Theophylline: New perspectives for an old drug. Am J Respir Crit Care Med 2003; 167: 813–818
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Pauwels RA. Theophylline in the management of asthma: Time for reappraisal?. Eur Respir J 1994; 7: 579–591
   PubMed Web of Science ®Google Scholar
• Bosquillon C, Lombry C, Preat V, Vanbever R. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Contr Rel 2000; 70: 329–339
   Google Scholar
• Bosquillon C, Rouxhet PG, Ahimou F, Simon D, Culot C, Preat V, et al. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Contr Rel 2004; 99: 357–367
   PubMed Web of Science ®Google Scholar
• Callens C, Remon JP. Evaluation of starch–maltodextrin–Carbopol® 974 P mixtures for the nasal delivery of insulin in rabbits. J Contr Rel 2000; 66: 215–220
   PubMed Web of Science ®Google Scholar
• Chawla V, Tiwary AK, Gupta S. Characterization of polyvinylalcohol microspheres of diclofenac sodium: Application of statistical design. Drug Dev Ind Pharm 2000; 26: 675–680
   PubMed Web of Science ®Google Scholar
• Cherdoud-Chihani A, Mouzali M, Abadie MJM. Study of crosslinking acid copolymer/DGEBA Systems by FTIR. J Appl Polym Sci 2003; 87: 2033–2051
   Google Scholar
• Cryan SA. Carrier-based strategies for targeting protein and peptide drugs to the lungs. AAPS J 2005; 7: 20–41
   PubMed Web of Science ®Google Scholar
• Cushley MJ, Holgate ST. Bronchodilator actions of xanthine derivatives administered by inhalation in asthma. Thorax 1985; 40: 176–179
   PubMed Web of Science ®Google Scholar
• Delval F, Crini G, Bertini S, Morin-Crini N, Badot P, Vebrel J, Torri G. Characterization of crosslinked starch materials with spectroscopic techniques. J Appl Polym Sci 2004; 93: 2650–2663
   Google Scholar
• Edwards DA, Hanes J, Caponetti G, Hirkach J, Ben-Jebria A, Eskew ML, et al. Large porous particles for pulmonary drug delivery. Science 1997; 276: 1868–1871
   PubMed Web of Science ®Google Scholar
• Eriksson L, Johansson E, Kettaneh-Wold N, Wikstrom C, Wold S. Design of experiments—Principles and applications. Learnways, AB, Stockholm 2000
   Google Scholar
• Gonda I. Targeting by deposition. Pharmaceutical inhalation aerosols technology. 2nd ed, AJ Hickey. Dekker, New York 2004; 134: 65–88
   Google Scholar
• Heyder J, Svartengren MU. Basic principles of particle behavior in the human respiratory tract. Drug delivery to the lungs, H Bisgaard, C O’Callaghan, CG Smaldone. Dekker, New York 2001; 162: 21–45
   Google Scholar
• Horton GE. The value and safety of nebulised aminophylline in acute bronchial asthma. J Tenn Med Ass 1966; 59: 239–244
   PubMedGoogle Scholar
• International Commission on Radiological Protection. Human respiratory model for radiological protection (ICRP Publication 66). Ann ICRP 1994; 24:1–120
   Google Scholar
• Köbrich R, Rudolf G, Stahlhofen W. A mathematical model of mass deposition in man. Ann Occup Hyg 1994; 38: 15–23
   Google Scholar
• Kaliner MA, Barnes PJ, Persson CGA. Asthma: Its pathology and treatment, Vol. 49. Dekker, New York 2001; 178–180
   Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983; 15: 25–35
   Web of Science ®Google Scholar
• Kramarenko MP. Treatment of bronchial asthma with euphyllin aerosols (preliminary report). Clin Med 1961; 39: 110–112
   Google Scholar
• Kunal P, Banthia AK, Majumdar DK. Starch based hydrogel with potential biomedical application as artificial skin. Afr J Biomed Res 2006; 9: 23–29
   Google Scholar
• Larionova NV, Kazanskaya NF, Larionova1 NI, Ponchel G, Duchene D. Preparation and characterization of microencapsulated proteinase inhibitor aprotinin. Biochemistry (Moscow) 1999; 64: 857–862
   PubMed Web of Science ®Google Scholar
• Lee SJ, Rosenberg M. Preparation and properties of glutaraldehyde cross-linked whey protein-based microcapsules containing theophylline. J Contr Rel 1999; 61: 123–136
   PubMed Web of Science ®Google Scholar
• Levy RJ, Schoen RJ, Levy JT, Nelson AC, Howard SL, Oshry LJ. Biologic determinants of dystrophic calcification and osteocalcin deposition in glutaraldehyde-preserved porcine aortic valve leaflets implanted subcutaneously in rats. Am J Pathol 1983; 113: 142–155
   Google Scholar
• Magenheim B, Benita S. The use of factorial design in the development of nanoparticulate dosage forms. Microencapsulation: Methods and industrial applications, S Benita. Dekker, New York 1996; 733: 93–131
   Google Scholar
• Merritt K. Systemic toxicity and hypersensitivity. Biomaterials science: An introduction to materials in medicine 1st ed, BD Ratner, AS Hoffman, FJ Schoen, JE Lemons. Academic Press, California 1996; 188–189
   Google Scholar
• National Institute of Health, Guidelines for the diagnosis and management of asthma. National asthma education program expert panel report. 1991. DHHS publication No. 91-3042
   Google Scholar
• Ogilvie RI, Fernandez PG, Winsberg F. Cardiovascular response to increasing theophylline concentrations. Eur J Din Pharmacol 1977; 12: 409–414
   Google Scholar
• Park JH, Ye M, Park K. Biodegradable polymers for microencapsulation of drug. J Molecules 2005; 10: 146–161
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256–1276
   PubMedGoogle Scholar
• Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 1985; 60: 110–111
   PubMedGoogle Scholar
• Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Contr Rel 2005; 110: 130–140
   PubMed Web of Science ®Google Scholar
• Reed CE, Offord KP, Nelson HS, Li JT, Tinkelman DG. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild-to-moderate asthma. J Allergy Clin Immunol 1998; 101: 14–23
   PubMed Web of Science ®Google Scholar
• Scheuch G, Kohlhaeufl MJ, Brand P, Siekmeier R. Clinical perspectives on pulmonary systemic and macromolecular delivery. J Adv Drug Deliv Rev 2006; 58: 996–1008
   PubMed Web of Science ®Google Scholar
• Schulz H, Brand P, Heyder J. Particle deposition in the respiratory tract. Lung biology in health and disease, C Lenfant. Dekker, New York, Basel 2000; 143: 229–290
   Google Scholar
• Shahin SM, Yamaura K. Preparation of theophylline hydrogels of atactic poly(vinyl alcohol)/NaCl/H2O system for drug delivery system. J Contr Rel 2002; 81: 367–377
   PubMedGoogle Scholar
• Sinclair GW, Peppas NA. Analysis of non-Fickian transport in polymers using simplified exponential expressions. J Membrane Sci 1984; 17: 329–331
   Web of Science ®Google Scholar
• Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev 2007; 59: 852–882
   PubMed Web of Science ®Google Scholar
• Svartengren M, Svartengren K, Aghaie F, Philipson K, Camner P. Lung deposition and extremly slow inhalations of particles: Limited effect of induced airway constriction. Exp Lung Res 1999; 25: 353–366
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 2001; 47: 39–54
   PubMed Web of Science ®Google Scholar
• Thompson DC. Pharmacology of therapeutic aerosols. Pharmaceutical inhalation aerosols technology. 2nd ed, AJ Hickey. Dekker, New York 2004; 134: 30–65
   Google Scholar
• Tuovinen L, Peltonen S, Liikola M, Hotakainen M, Lahtela-Kakkonen M, Poso A, et al. Drug release from starch-acetate microparticles and films with and without incorporated α-amylase. Biomaterials 2004; 25: 4355–4362
   PubMedGoogle Scholar
• Vanbever R, Mintzes JD, Wang J, Nice J, Chen D, Batycky R, et al. Formulation and physical charechterization of large porous particles for inhalation. Pharm Res 1999; 16: 1735–1742
   PubMed Web of Science ®Google Scholar
• Yano Y, Yoshida M, Hoshino S, Inoue K, Kida H, Yanagita M, Takimoto T, Kumagai T, Osaki T, Tachibana I. Anti-fibrotic effects of theophylline on lung fibroblasts. Biochem Biophs Res Commun 2006; 341: 684–690
   PubMedGoogle Scholar
• Zhang WF, Chen XG, Li PW, He QZ, Zhou HY. Preparation and characterization of theophylline loaded chitosan/b-cyclodextrin microspheres. J Mater Sci Mater Med 2008; 19: 305–310
   PubMed Web of Science ®Google Scholar